Browse by Aston Author
Up a level |
Stokes, C.A., Kaur, R., Edwards, M.R., Mondhe, M., Robinson, D., Prestwich, E.C., Hume, R.D., Marshall, C.A., Perrie, Y., O'Donnell, V.B., Harwood, J.L., Sabroe, I. and Parker, L.C. (2016). Human rhinovirus-induced inflammatory responses are inhibited by phosphatidylserine containing liposomes. Mucosal Immunology, 9 (5), pp. 1303-1316.
Kastner, Elisabeth, Kaur, Randip, Lowry, Deborah, Moghaddam, Behfar, Wilkinson, Alexander and Perrie, Yvonne (2014). High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization. International Journal of Pharmaceutics, 477 (1-2), pp. 361-368.
Kaur, Randip, Henriksen-Lacey, Malou, Wilkhu, Jitinder, Devitt, Andrew, Christensen, Dennis and Perrie, Yvonne (2014). Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on Bilayer properties, biodistribution, and immune responses. Molecular pharmaceutics, 11 (1), pp. 197-207.
Perrie, Yvonne, Kastner, Elisabeth, Kaur, Randip, Wilkinson, Alexander and Ingham, Andrew J. (2013). A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant. Human Vaccines and Immunotherapeutics, 9 (6), pp. 1374-1381.
Kirby, Daniel J., Kaur, Randip, Agger, Else M., Andersen, Peter, Bramwell, Vincent W. and Perrie, Yvonne (2013). Developing solid particulate vaccine adjuvants - surface bound antigen favouring a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current drug delivery, Epub a ,
Kirby, Daniel J., Kaur, Randip, Agger, Else M., Andersen, Peter, Bramwell, Vincent W. and Perrie, Yvonne (2013). Developing solid particulate vaccine adjuvants:surface bound antigen favouring a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current Drug Delivery, 11 (6), pp. 268-278.
Milicic, Anita, Kaur, Randip, Reyes-Sandoval, Arturo, Tang, Choon-Kit, Honeycutt, Jared, Perrie, Yvonne and Hill, Adrian V.S. (2012). Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. PLoS ONE, 7 (3),
Kaur, Randip, Chen, Jili, Dawoodji, Amina, Cerundolo, Vincenzo, Garcia-Diaz, Yoel R., Wojno, Justyna, Cox, Liam R., Besra, Gurdyal S., Moghaddam, Behfar and Perrie, Yvonne (2011). Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells. Journal of Pharmaceutical Sciences, 100 (7), pp. 2724-2733.
Kaur, Randip (2011). Liposomes:Formulation and characterisation as contrast agents and as vaccine delivery systems. PHD thesis, Aston University.